K, J., M, S., & W, X. (2018). Arginine, glycine, aspartic acid peptide-modified paclitaxel and curcumin co-loaded liposome for the treatment of lung cancer: In vitro/vivo evaluation. Dove Medical Press.
Chicago Style (17th ed.) CitationK, Jiang, Shen M, and Xu W. Arginine, Glycine, Aspartic Acid Peptide-modified Paclitaxel and Curcumin Co-loaded Liposome for the Treatment of Lung Cancer: In Vitro/vivo Evaluation. Dove Medical Press, 2018.
MLA (8th ed.) CitationK, Jiang, et al. Arginine, Glycine, Aspartic Acid Peptide-modified Paclitaxel and Curcumin Co-loaded Liposome for the Treatment of Lung Cancer: In Vitro/vivo Evaluation. Dove Medical Press, 2018.
Warning: These citations may not always be 100% accurate.